Free pharmaceutical policy to promote equity and access:Its implications for China

Xiao-dong GUAN,Bao-min WANG,Xiao-xiong XIN,Zhi-gang GUO,Sheng HAN,Lu-wen SHI
DOI: https://doi.org/10.3969/j.issn.1674-2982.2015.02.009
2015-01-01
Abstract:Promoting equity and access to medicine is important to guarantee health equity. The international communities commonly guarantee equity and access to medicine through free pharmaceutical policy. In most coun-tries, free pharmaceutical policy covers patients who cannot afford, children under 5, pregnant women and elderly people. The free medicines include essential medicines, medicines for chronic and infectious diseases, vaccines, etc. Financing of free medicines comes from health insurance, direct government investment and international aid, and the medicine delivery mainly depends on the public medical institutions. Free pharmaceutical policy in China mainly refers to medicines for infectious diseases and vaccines, and the coverage is narrow. This paper argues that since China has been becoming one of the middle income countries, the amount of free medicines should be in-creased, especially for chronic diseases, such as diabetes, hypertension, etc. The equity and access to medicine in China should be further promoted by providing all essential medicines for free.
What problem does this paper attempt to address?